Drug intelligence / Profile preview

Virivital

Development stage: Unknown
Lead developer: Ruhrpharm
Administration: Oral

Overview

Virivital is an oral dietary supplement developed and marketed by Ruhrpharm AG as a specialized vital substance complex for men's health. It is formulated as a combination of multiple active ingredients, including soybean extract (providing soy isoflavones), fish oil (providing omega-3 fatty acids), lycopene, L-carnitine, vitamin E, vitamin C, folic acid, coenzyme Q10, zinc, and selenium. Virivital is designed to support energy metabolism, immune function, and cellular protection against oxidative stress.

Brand names: Virivital

Beyond the preview

Go deeper on Virivital.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Virivital.

Explore the full profile